VERYAN ENDOVASCULAR
Veryan Medical is a medical device company based in Galway. Veryan has recruited an experienced team of medical device professionals to commercialise its unique BioMimics 3D stent technology. The company recently secured a €5m venture capital investment led by Seroba Kernel Life Sciences and Imperial Innovations Group. The stent platform aims to mimic the natural shape and geometry of the human vascular system. It involves transposing a 3D helical shape onto a traditional straight stent. Pr... e-clinical studies have shown that BioMimics3D stents are more flexible, more kink resistant and more fracture resistant than straight stents. They also impart a swirling flow of blood through the stent, which has been shown to reduce restenosis (the re-narrowing of stented arterial segments). Veryan have completed human clinical trials and expect to CE Mark the product during 2012.
VERYAN ENDOVASCULAR
Industry:
Health Care Medical
Address:
Galway, Galway, Ireland
Country:
Ireland
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Atche Medical
Development of New Medical Device Ventures
Syrolight
phototherapeutic medical devices
Telecomunicaciones Domótica Internacional
Development of competative products.
Topos Medical
Development of surgical instruments
Current Employees Featured
More informations about "Veryan Endovascular"
about-us - Veryan Medical
Veryan was founded in 2005 as the result of a technology spin out from Imperial College, London. Manage Consent. To provide the best experiences, we use technologies like cookies to store …See details»
Veryan Endovascular - Crunchbase Company Profile & Funding
Veryan Medical is a medical device company based in Galway. Veryan has recruited an experienced team of medical device professionals to commercialise its unique BioMimics 3D …See details»
Veryan Medical Ltd. - Manufacturer Of Human Vascular System
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) …See details»
Otsuka Medical Devices Acquires Veryan Medical - Endovascular …
Dec 13, 2018 Veryan’s Research & Development operations in Galway, Ireland, will be retained by Otsuka Medical Devices and will play a key role in the continued development of the …See details»
Veryan Endovascular - Drug pipelines, Patents, Clinical trials
Last update 19 Sep 2024. Veryan Endovascular. Private Company |See details»
Product Introduction-Endovastec
Veryan BM3D™ BioMimics 3D Peripheral Self-Expanding Stent System is designed for the treatment of symptomatic de novo lesions in the native superficial femoral artery (SFA) and/or …See details»
VERYAN ENDOVASCULAR LIMITED - Companies House
Mar 25, 2014 More for VERYAN ENDOVASCULAR LIMITED (06289506) Registered office address MANCHES LLP, 9400 Garsington Road Oxford Business Park, Oxford, Oxfordshire, …See details»
Veryan Medical on LinkedIn: #cmo #endovascular #clifighters # ...
Peter Gaines has been Veryan’s Chief Medical officer since 2007, we would like to extend our sincere gratitude for his advice and counsel over the past 16-years! He is now retiring to …See details»
BioMimics 3D® Vascular Stent System - Veryan Medical
Veryan has developed innovative technology to improve the performance of vascular stents by adopting the principle of biomimicry; developing structures that imitate those occurring …See details»
Otsuka Medical Devices completes aquisition of Veryan Medical
Dec 13, 2018 This will allow Veryan to build on the strong clinical data with the BioMimics stent and realise the potential to significantly advance the treatment of peripheral vascular disease.” …See details»
Otsuka Medical Devices and Veryan Medical Announce …
Dec 13, 2018 Veryan’s BioMimics 3D peripheral vascular stent received U.S. FDA approval on 4 October, 2018. Following the acquisition, Veryan and Otsuka Medical Devices plan to …See details»
Veryan Medical Ltd. - Radcliffe Vascular
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) …See details»
Veryan - Home
Veryan Medical Limited is a member of the Otsuka Medical Devices group of companies. CAUTION: Federal law restricts this device to sale by or on the order of a physician. PAM 14 …See details»
Veryan Endovascular - Contacts, Employees, Board Members
Experience the new Crunchbase, powered by AI . Organization. Veryan EndovascularSee details»
Veryan Launches BioMimics 3D Vascular Stent System
September 1, 2020—Veryan Medical announced the United States launch of the company's BioMimics three-dimensional (3D) vascular stent system, Created with Sketch. News Issue …See details»
EXECUTIVE TEAM - Veryan Medical
Veryan has an industry leading Executive team with deep sector expertise, a proven track record and over 200 years’ experience in Healthcare. They bring significant core competencies in …See details»
Veryan Medical announces multimillion-euro investment in Galway ...
News & Events Veryan Medical announces multimillion-euro investment in Galway operation. 1st April 2021. Veryan has announced a multimillion-euro investment at its Galway facility that will …See details»
Veryan’s BioMimics 3D Stent Evaluated in Longer ... - Endovascular …
November 3, 2022—A post hoc subgroup analysis of the prospective, single-arm, multicenter MIMICS-3D EU registry investigated the 3-year performance of the BioMimics 3D three …See details»
About us - Veryan Medical
Veryan became an Otsuka Medical Devices company in 2018. Otsuka Medical Devices is a member of the Otsuka group, a total healthcare company. The Otsuka group advances …See details»
FDA Approves Veryan Medical's BioMimics 3D ... - Endovascular …
Oct 4, 2018 Veryan reported that the MIMICS-2 study met both of its primary endpoints of safety and effectiveness. Freedom from major adverse events at 30 days was 99.6% (268/269) and …See details»